Astrana Health, Inc. (ASTH): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$596.14M
Year ended 2021-12-31
+18.2%
3-year compound annual growth
2017-12-31: $273.45M2018-12-31: $361.13M2019-12-31: $467.81M2020-12-31: $539.21M2021-12-31: $596.14M$596.14M
2017-12-31 Cost of Revenue (USD) 2021-12-31
Period endedCost of RevenueChange YoYSource filing
2021-12-31$596.14M+10.6%2022-02-28, From 2021-01-01
2020-12-31$539.21M+15.3%2022-02-28, From 2020-01-01
2019-12-31$467.81M+29.5%2022-02-28, From 2019-01-01
2018-12-31$361.13M+32.1%2021-03-15, From 2018-01-01
2017-12-31$273.45Mn/a2020-03-16, From 2017-01-01